Want to see LDOS full AI Analyst Report?
LDOS Stock Chart & Stats
$112.14
$2.81(2.51%)
At close: 4:00 PM EDT
$112.14
$2.81(2.51%)
Day’s Range― - ―
52-Week Range$98.86 - $205.77
Previous Close$114.54
Volume1.39M
Average Volume (3M)1.80M
Market Cap
$17.37B
Enterprise Value$19.51K
Total Cash (Recent Filing)$748.00M
Total Debt (Recent Filing)$6.58B
Price to Earnings (P/E)12.8
Beta0.80
Next Earnings
Nov 03, 2026EPS Estimate
3.05Next Dividend Ex-DateN/A
Dividend Yield1.26%
Share Statistics
EPS (TTM)10.81
Shares Outstanding125,492,210
10 Day Avg. Volume1,388,314
30 Day Avg. Volume1,798,922
Financial Highlights & Ratios
PEG Ratio0.82
Price to Book (P/B)4.94
Price to Sales (P/S)1.41
P/FCF Ratio14.95
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$149.83Price Target Upside33.61% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering14
EPS Forecast (FY)12.38
Revenue Forecast (FY)$18.32B
Bulls Say, Bears Say
Bulls Say
Exceptional Cash GenerationStrong operating and free cash flow supports internal investment, debt reduction and shareholder returns. FCF closely tracking earnings also indicates solid earnings quality, although working-capital movements remain a monitoring point.
Defense Demand And Backlog StrengthHigh defense bookings and a large pipeline improve revenue visibility in mission-critical markets. Awards spanning munitions, satellites, maritime systems and counter-UAS can support multi-year growth and reinforce Leidos's government position.
Raised Outlook And Margin ResilienceHigher guidance alongside maintained margins signals durable execution and better operating visibility. Management expects approximately 7% organic revenue growth and 19% adjusted EBITDA growth outside the Health segment, supporting the broader portfolio.
Bears Say
Elevated Balance-Sheet LeverageLeverage increases financial risk and reduces flexibility if government spending, contract performance or cash conversion weakens. Although equity has grown and returns are strong, debt remains a meaningful constraint on resilience.
Modest Top-Line GrowthLimited recent revenue expansion suggests the current business is more steady than high-growth. Sustaining earnings improvement may therefore depend on margin execution, contract mix and successful conversion of the defense and digital pipeline.
Health Segment Structural UncertaintyHealth risks could pressure revenue, margins and the long-term business mix. The VBA recompete remains uncertain, while in-sourcing and commercial software adoption may reduce integration opportunities or alter contract economics over time.
Leidos Holdings News
LDOS FAQ
What was Leidos Holdings Inc’s price range in the past 12 months?
Leidos Holdings Inc lowest stock price was $98.86 and its highest was $205.77 in the past 12 months.
What is Leidos Holdings Inc’s market cap?
Leidos Holdings Inc’s market cap is $17.37B.
When is Leidos Holdings Inc’s upcoming earnings report date?
Leidos Holdings Inc’s upcoming earnings report date is Nov 03, 2026 which is in 69 days.
How were Leidos Holdings Inc’s earnings last quarter?
Leidos Holdings Inc released its earnings results on Aug 04, 2026. The company reported $3.26 earnings per share for the quarter, beating the consensus estimate of $2.908 by $0.352.
Is Leidos Holdings Inc overvalued?
According to Wall Street analysts Leidos Holdings Inc’s price is currently Undervalued.
Does Leidos Holdings Inc pay dividends?
Leidos Holdings Inc pays a Quarterly dividend of $0.43 which represents an annual dividend yield of 1.26%. See more information on Leidos Holdings Inc dividends here
What is Leidos Holdings Inc’s EPS estimate?
Leidos Holdings Inc’s EPS estimate is 3.05.
How many shares outstanding does Leidos Holdings Inc have?
Leidos Holdings Inc has 125,492,210 shares outstanding.
What happened to Leidos Holdings Inc’s price movement after its last earnings report?
Leidos Holdings Inc reported an EPS of $3.26 in its last earnings report, beating expectations of $2.908. Following the earnings report the stock price went up 10.007%.
Which hedge fund is a major shareholder of Leidos Holdings Inc?
Currently, no hedge funds are holding shares in LDOS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Leidos Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$149.83 (33.61% Upside)
$149.83 (33.61% Upside)
Blogger Sentiment
Bullish
LDOS Sentiment 77%
Sector Average 59%
Sector Average 59%
Hedge Fund Trend
Increased
By 2.3M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 1.2%
Last 30 Days ▼ 1.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-28.84%
12-Months-Change
Fundamentals
Return on Equity
1.26%
Trailing 12-Months
Asset Growth
15.37%
Trailing 12-Months
Company Description
Leidos Holdings Inc
Leidos Holdings, Inc., along with its various subsidiaries, delivers a broad spectrum of services and innovative solutions across key markets: defense, intelligence, civil government, and health. The company operates both domestically within the United States and on an international scale. Its operations are organized into three principal divisions: Defense Solutions, Civil, and Health. The Defense Solutions segment is dedicated to providing national security systems and specialized support spanning air, land, sea, space, and cyberspace domains. Its extensive client base includes the U.S. Intelligence Community, the Department of Defense, NASA, various military branches, allied foreign governments, and other federal and commercial entities within the national security sector. This division's offerings encompass advanced technology, large-scale systems integration, command and control platforms, sophisticated data analytics, logistics, robust cybersecurity defenses, and crucial intelligence analysis and operational support for critical missions. The Civil segment offers systems integration capabilities primarily to air navigation service providers, such as the Federal Aviation Administration (FAA). This involves critical programs like En Route Automation Modernization (ERAM), Advanced Technology Oceanic Procedure (ATOP), Time Based Flow Management (TBFM), Terminal Flight Data Management (TFDM), GEO-7, and Future Flight Services, as well as developing enterprise-wide information display systems. Additionally, this segment provides security detection and automation services. Its portfolio further extends to comprehensive information technology (IT) solutions, covering areas like cloud computing, mobility, application modernization, DevOps, data center operations, network upgrades, asset management, help desk support, and digital workplace enablement. Environmental, energy, and infrastructure services also fall under this division. Finally, the Health segment furnishes solutions to both federal and commercial clients globally, focusing on initiatives that promote human health and well-being. This includes services such as health information management, managed healthcare programs, digital transformation projects, and support for life sciences research and development. Leidos Holdings, Inc. was established in 1969 and is based out of Reston, Virginia.
LDOS Company Deck
LDOS Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed solid overall financial performance with record revenue, strong margins and exceptional cash generation, plus accelerating Defense momentum and a large near-term pipeline of proposals. Management raised full-year guidance and reduced leverage while completing share repurchases and progressing strategic actions (Entrust integration, SES JV). Key negatives center on the Health segment: the VA's suspension of incentive payments, near-term revenue/margin pressure from the MDE market and some uncertainty around MHS GENESIS and agency in-sourcing trends. Management indicates these health headwinds are largely accounted for in the updated guidance and expects offset from Defense, Homeland and digital growth pillars.View all LDOS earnings summariesLDOS Revenue Breakdown
44.20% National Security & Digita
30.10% Health & Civil
13.52% Commercial & International
12.18% Defense Systems

LDOS Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$149.83
▲(33.61% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Ownership Overview
0.75% Insiders
20.74% Mutual Funds
8.40% Other Institutional Investors
34.83% Public Companies and
Individual Investors










